Antimetabolites: all 8,294 studies that test it
Page 75 of 83. Open to participants first (1,149), then studies with results posted, then the rest; newest registration first within each.
- Rituximab, Carmustine; Cytarabine, Etoposide, & Melphalan; Stem Cell Transplantation for Non-Hodgkin's LymphomaCompletedNCT00080886Phase 2
- Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the UrotheliumCompletedNCT00080795Phase 2
- Pemetrexed Plus a Comparator Versus a Combination of 2 Comparators in First-Line Treatment of Colorectal CancerCompletedNCT00079872Phase 2
- Study of CEP-701 (Lestaurtinib) in Patients With Acute Myeloid Leukemia (AML)CompletedNCT00079482Phase 2
- FR901228 Alone or Combined With Rituximab and Fludarabine in Treating Patients With Relapsed or Refractory Low-Grade B-Cell Non-Hodgkin's LymphomaTerminatedNCT00079443Phase 2
- Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaCompletedNCT00079378Phase 1
- Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the PancreasStatus unknownNCT00079365Not applicable
- Flavopiridol, Gemcitabine, and Irinotecan in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT00079352Phase 1
- Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00079287Phase 3
- Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's LymphomaCompletedNCT00079261Phase 2
- Cisplatin or Carboplatin Combined With Gemcitabine in Locally Advanced, Recurrent, or Metastatic Malignant Salivary Gland TumorCompletedNCT00079079Phase 2
- 3-AP and Gemcitabine in Treating Patients With Recurrent, Unresectable, or Metastatic Pancreatic CancerCompletedNCT00078975Phase 2
- GTI-2040 and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00078962Phase 1
- Study of the GARFT Inhibitor AG2037 in Patients With Metastatic Colorectal Cancer Who Failed TreatmentCompletedNCT00078468Phase 2
- A Comparison of Two Doses of Pemetrexed in Patients Who Have Lung CancerCompletedNCT00078260Phase 3
- 3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic SyndromeCompletedNCT00077558Phase 1
- 3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung CancerCompletedNCT00077415Phase 2
- Capecitabine and Tipifarnib in Treating Women With Taxane-Resistant Metastatic Breast CancerCompletedNCT00077363Phase 2
- A Phase II Trial of Triapine (NSC #663249) in Combination With Gemcitabine as Second Line Treatment of Non-Small Cell Lung CancerCompletedNCT00077350Phase 2
- 3-AP and High-Dose Cytarabine in Treating Patients With Advanced Hematologic MalignanciesCompletedNCT00077181Phase 1
- Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic SyndromeCompletedNCT00077116Phase 2
- DJ-927 and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT00077077Phase 1
- Cytochlor and Tetrahydrouridine as Radiosensitizers and Cisplatin Combined With Radiation Therapy in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity (Mouth) or Oropharynx (Throat)CompletedNCT00077051Phase 1
- Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular CarcinomaCompletedNCT00076609Phase 1/2
- Alanosine in Treating Patients With Progressive or Recurrent Malignant GliomasCompletedNCT00075894Phase 1
- Gemcitabine, Carboplatin, and Bortezomib in Advanced or Recurrent Non-Small Cell Lung CancerCompletedNCT00075751Phase 2
- Fluorouracil, Irinotecan, Leucovorin, and Cisplatin as First-Line Therapy in Treating Patients With Metastatic Esophageal CancerStatus unknownNCT00075738Phase 2
- Decitabine, Doxorubicin, and Cyclophosphamide in Treating Children With Relapsed or Refractory Solid Tumors or NeuroblastomaCompletedNCT00075634Phase 1
- Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal CancerStatus unknownNCT00075595Phase 2
- Neoadjuvant Radiation Therapy and Capecitabine in Treating Patients With Stage III or Stage IV Colorectal AdenocarcinomaStatus unknownNCT00075556Phase 2
- Gemcitabine and Docetaxel in Treating Patients With Inoperable Stage IIIB or Stage IV Non-Small Cell Lung CancerStatus unknownNCT00075517Phase 2
- Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic AdenocarcinomaStatus unknownNCT00075452Phase 3
- Phase I/II Study of Decitabine and Valproic Acid in Relapsed/Refractory Leukemia or Myelodysplastic SyndromesCompletedNCT00075010Phase 1/2
- Dosing Study of Ara-C/EL625/Idarubicin in Refractory and Relapsed AMLCompletedNCT00074737Phase 2
- Intrathecal Gemcitabine to Treat Neoplastic Meningitis, IT GemcitabineTerminatedNCT00074607Phase 1
- Irinotecan, Oxaliplatin, and Capecitabine in Treating Patients With Unresectable Solid TumorsCompletedNCT00074321Phase 1
- Gemcitabine and Carboplatin Followed By Docetaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00074204Phase 3
- Methotrexate, Procarbazine, Lomustine, Dexamethasone, and Cytarabine in Treating Patients With Primary CNS LymphomaCompletedNCT00074191Phase 2
- Methotrexate, Cyclophosphamide, and Etoposide Phosphate Given With Osmotic Blood-Brain Barrier Disruption Plus Dexamethasone and Cytarabine in Treating Patients With Primary CNS LymphomaCompletedNCT00074178Phase 2
- Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract CancerCompletedNCT00073905Phase 2
- Fludarabine, Cyclophosphamide, and Alemtuzumab in Treating Patients With Recurrent or Metastatic Renal Cell Carcinoma (Kidney Cancer) Undergoing Allogeneic Stem Cell TransplantationCompletedNCT00073879Not applicable
- Safety and Tolerability of I.V. Infusion of MB07133 in Patients With Unresectable Hepatocellular CarcinomaCompletedNCT00073736Phase 1/2
- Phase II Study of Single Agent OSI-7904L in Patients With Gastric or Gastroesophageal (GEJ) CancerCompletedNCT00073502Phase 2
- Pemetrexed and Carboplatin in Locally Advanced or Metastatic Breast CancerCompletedNCT00072865Phase 2
- Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal CancerStatus unknownNCT00072553Phase 2
- Gemcitabine Hydrochloride and Alvocidib in Treating Patients With Solid TumorsCompletedNCT00072436Phase 1
- Soblidotin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Solid TumorsWithdrawnNCT00072228Phase 1
- Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With CLLCompletedNCT00072007Phase 2
- Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00071136Phase 1/2
- GTI-2040 and High-Dose Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid LeukemiaCompletedNCT00070551Phase 1
- VNP40101M and Cytarabine in Treating Patients With Hematologic MalignanciesCompletedNCT00070538Phase 1
- Pemetrexed Disodium in Treating Young Patients With Recurrent Solid TumorsCompletedNCT00070473Phase 1
- S0304 Induct Chemo Then Chemo-RT in Pts w/Locally Advanced Adenocarcinoma of the RectumWithdrawnNCT00070434Phase 2
- Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's LymphomaCompletedNCT00070304Phase 2
- Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast CancerStatus unknownNCT00070278Phase 3
- Neoadjuvant and Adjuvant Capecitabine and Oxaliplatin in Treating Patients With Resectable Liver Metastases Secondary to Colorectal CancerTerminatedNCT00070265Phase 2
- Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast CancerCompletedNCT00070252Phase 1/2
- Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal CancerCompletedNCT00070213Phase 3
- Total-Body Irradiation, Fludarabine, and Alemtuzumab Followed By Stem Cell Transplant in Treating Patients With Myeloproliferative Disorder, MS, AML, or CMLTerminatedNCT00069992Phase 2
- Pixantrone, Cytarabine, Methylprednisolone, and Cisplatin in Treating Patients With Aggressive Non-Hodgkin's Lymphoma in First RelapseStatus unknownNCT00069966Phase 2
- A Study With Gemcitabine, Cisplatin, and LY293111 in Non-Small Cell Lung CancerCompletedNCT00069875Phase 2
- Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal CancerTerminatedNCT00068744Phase 2/3
- Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical CancerCompletedNCT00068549Phase 1
- Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00068432Phase 2
- Bortezomib and Fludarabine With or Without Rituximab in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaCompletedNCT00068315Phase 1
- Bevacizumab Plus Fluorouracil and Leucovorin in Treating Patients With Locally Advanced or Metastatic Stage IV Colorectal Cancer That Has Progressed After Standard ChemotherapyCompletedNCT00066846Phase 2
- S0301 Cyclosporine, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid LeukemiaCompletedNCT00066794Phase 2
- Suramin and Either Docetaxel or Gemcitabine in Treating Patients With Stage IIIB or Stage IV Platinum-Refractory Non-Small Cell Lung CancerCompletedNCT00066768Phase 1
- Pemetrexed as First Line Chemotherapy for Advanced Breast CancerCompletedNCT00065533Phase 2
- Clofarabine Plus Cytarabine in Patients With Previously Untreated Acute Myeloid Leukemia and High-risk Myelodysplastic SyndromeCompletedNCT00065143Phase 2
- Safety, Tolerability and Efficacy of ZD6126 in Combination With Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects With Metastatic Colorectal Cancer.TerminatedNCT00065117Phase 2
- Gemcitabine and Radiation Therapy Compared With Gemcitabine Alone in Treating Patients Who Have Undergone Surgery for Pancreatic CancerCompletedNCT00064207Phase 2/3
- Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal CancerCompletedNCT00064181Phase 3
- 3-AP and Cytarabine in Treating Patients With Hematologic CancerCompletedNCT00064090Phase 1
- 3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung CancerCompletedNCT00064064Phase 2
- 3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic CancerCompletedNCT00064051Phase 2
- Hepatic Arterial Infusion With Floxuridine and Systemic Irinotecan After Surgery in Treating Patients With Hepatic (Liver) Metastases From Colorectal CancerCompletedNCT00063960Phase 2
- Erlotinib, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic CancerCompletedNCT00063947Phase 1
- Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal CancerCompletedNCT00062426Phase 3
- Alanosine in Treating Patients With CancerCompletedNCT00062283Phase 2
- Neoadjuvant Chemoradiotherapy With or Without Gefitinib in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung CancerCompletedNCT00062270Phase 1/2
- Cyclophosphamide and Fludarabine Followed By Interleukin-2 Gene-Modified Tumor Infiltrating Lymphocytes in Treating Patients With Metastatic MelanomaCompletedNCT00062036Phase 1/2
- Phase I Study of Continuous Infusion Schedule of FMdC in Hematologic MalignanciesCompletedNCT00061620Phase 1
- Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal MesotheliomaCompletedNCT00061477Phase 2
- Pemetrexed Plus Gemcitabine for Patients With Locally Advanced or Metastatic NSCLC Who Have Not Had Previous Chemotherapy.CompletedNCT00061464Phase 2
- Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Clinical TrialCompletedNCT00061451Phase 2
- Second-line Intravenous Treatment For Recurrent Platinum-Sensitive Ovarian, Fallopian, Or Peritoneal CancerCompletedNCT00061308Phase 2
- Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's LymphomaCompletedNCT00060684Phase 1
- A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Pancreatic Cancer Related CachexiaCompletedNCT00060502Phase 2
- A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal CancerCompletedNCT00060411Phase 1
- Oblimersen and Gemcitabine in Treating Patients With Advanced Solid Tumor or LymphomaTerminatedNCT00060112Phase 1
- Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal CancerCompletedNCT00059930Phase 1
- Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder CancerCompletedNCT00059865Phase 1/2
- Erlotinib and Gemcitabine in Treating Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline and/or a TaxaneCompletedNCT00059852Phase 2
- Adjuvant Chemoradiotherapy and Interferon Alfa in Treating Patients With Resected Pancreatic CancerCompletedNCT00059826Phase 2
- Zidovudine Levels in HIV Infected Patients Being Treated for HCVCompletedNCT00059358Phase 1/2
- Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal CancerStatus unknownNCT00058474Phase 3
- S0312, Gemcitabine and Capecitabine in Treating Patients With Advanced Renal Cell (Kidney) CancerCompletedNCT00058318Phase 2
- Radiolabeled Monoclonal Antibody Therapy and High-Dose Chemotherapy Followed By Autologous Peripheral Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaCompletedNCT00058292Phase 1
- Alvocidib, Fludarabine Phosphate, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell LymphomaCompletedNCT00058227Phase 1